Literature DB >> 30445459

Intestinal Glucose Absorption Is a Key Determinant of 1-Hour Postload Plasma Glucose Levels in Nondiabetic Subjects.

Domenico Tricò1,2, Alessandro Mengozzi1, Silvia Frascerra1, Maria Tiziana Scozzaro1, Andrea Mari3, Andrea Natali1.   

Abstract

CONTEXT: One-hour postload hyperglycemia, defined as 1-hour plasma glucose (1hPG) ≥ 155 mg/dL during an oral glucose tolerance test (OGTT), has been proposed as an independent predictor of type 2 diabetes. Recent evidence suggests that 1-hour hyperglycemia can be explained by enhanced duodenal glucose absorption, which in turn may increase the rate of appearance of oral glucose in the systemic circulation (RaO). However, the impact of RaO on 1hPG and 1-hour glucose excursions (incremental area under the curve calculated through the first hour after glucose ingestion; glucose iAUC1h) is still unknown.
OBJECTIVE: We quantified the relative contribution of postload RaO to 1hPG and glucose iAUC1h with respect to other major glucose homeostatic mechanisms in nondiabetic participants. PARTICIPANTS AND METHODS: Model-derived β-cell function, insulin clearance, glucose metabolic fluxes, and peripheral and hepatic insulin sensitivity were measured during a 75-g OGTT by a double tracer method in 23 nondiabetic volunteers.
RESULTS: Early insulin secretion, whole-body insulin sensitivity, and plasma glucose disposal were significantly impaired in participants with 1hPG ≥ 155 mg/dL (n = 11), who also showed nominally greater RaO (19%; P = 0.10). In multivariable models, postload RaO showed an independent effect on both 1hPG and glucose iAUC1h (partial r2 = 0.26 and 0.48, respectively; P < 0.003). The relative contribution of RaO to 1hPG (23%) and glucose iAUC1h (30%) was similar to that of early insulin secretion and peripheral insulin sensitivity and greater than that of hepatic insulin sensitivity.
CONCLUSIONS: Our data highlight the primary role of RaO as a major determinant of 1-hour postprandial glucose excursions in nondiabetic participants.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30445459     DOI: 10.1210/jc.2018-02166

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  1-h Glucose During Oral Glucose Tolerance Test Predicts Hyperglycemia Relapse-Free Survival in Obese Black Patients With Hyperglycemic Crises.

Authors:  Ram Jagannathan; Darko Stefanovski; Dawn D Smiley; Omolade Oladejo; Lucia F Cotten; Guillermo Umpierrez; Priyathama Vellanki
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-02       Impact factor: 6.055

2.  One-hour post-load plasma glucose predicts progression to prediabetes in a multi-ethnic cohort of obese youths.

Authors:  Domenico Tricò; Alfonso Galderisi; Andrea Mari; Nicola Santoro; Sonia Caprio
Journal:  Diabetes Obes Metab       Date:  2019-02-28       Impact factor: 6.577

Review 3.  Review of methods for detecting glycemic disorders.

Authors:  Michael Bergman; Muhammad Abdul-Ghani; Ralph A DeFronzo; Melania Manco; Giorgio Sesti; Teresa Vanessa Fiorentino; Antonio Ceriello; Mary Rhee; Lawrence S Phillips; Stephanie Chung; Celeste Cravalho; Ram Jagannathan; Louis Monnier; Claude Colette; David Owens; Cristina Bianchi; Stefano Del Prato; Mariana P Monteiro; João Sérgio Neves; Jose Luiz Medina; Maria Paula Macedo; Rogério Tavares Ribeiro; João Filipe Raposo; Brenda Dorcely; Nouran Ibrahim; Martin Buysschaert
Journal:  Diabetes Res Clin Pract       Date:  2020-06-01       Impact factor: 5.602

4.  Glutamate-Serine-Glycine Index: A Novel Potential Biomarker in Pediatric Non-Alcoholic Fatty Liver Disease.

Authors:  Simone Leonetti; Raimund I Herzog; Sonia Caprio; Nicola Santoro; Domenico Tricò
Journal:  Children (Basel)       Date:  2020-12-04

5.  Mechanistic Insights Into the Heterogeneity of Glucose Response Classes in Youths With Obesity: A Latent Class Trajectory Approach.

Authors:  Domenico Tricò; Sarah McCollum; Stephanie Samuels; Nicola Santoro; Alfonso Galderisi; Leif Groop; Sonia Caprio; Veronika Shabanova
Journal:  Diabetes Care       Date:  2022-08-01       Impact factor: 17.152

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.